Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in vitro and in vivo

Rashmi Rajappa(JSS Academy of Higher Education and Research), SubbaRao V. Madhunapantula(JSS Academy of Higher Education and Research)

Frontiers in Pharmacology

January 28, 2019

10.3389/fphar.2018.01562

Cited by 71

Related Papers

Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo

|Biomedicines|2021|44

Vitamin D3 Inhibits the Viability of Breast Cancer Cells In Vitro and Ehrlich Ascites Carcinomas in Mice by Promoting Apoptosis and Cell Cycle Arrest and by Impeding Tumor Angiogenesis

|Cancers|2023|20